Zentalis Pharmaceuticals Inc.
ZNTL | NASDAQ
$3.09
+$0.06 (+1.98%)
Sep 22, 2026, 10:20 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -77.64M | -35.35M | -35.22M | -26.69M | -26.87M | -48.28M | -47.47M | -40.16M | -88.28M | 10.07M | -60.92M | -55.54M | -112.56M | -63.26M | -54.98M | -54.5M | -68.39M | -59.24M | -50.06M | -10.49M | -55.06M | -49.9M |
Depreciation & Amortization | 304K | 151K | 157K | 160K | 160K | 262K | 317K | 321K | 327K | 324K | 337K | 348K | 344K | 360K | 359K | 375K | 348K | 344K | 209K | 137K | 119K | 79K |
Stock-Based Compensation | 6.41M | n/a | 3.12M | 4.83M | 6.29M | 6.49M | 31.36M | 10.36M | 12.71M | 12.83M | n/a | 13.87M | 13.34M | 13.73M | 9.61M | 10.32M | 16.76M | 10.15M | n/a | 7.66M | 9.92M | n/a |
Other Working Capital | 1M | 723K | -645K | -1.17M | 2.26M | 777K | 486K | 4.75M | 2.3M | -1.06M | -129K | -1.55M | -770K | -4.02M | -12.11M | 3.17M | -1.61M | -2.7M | 657K | 5.24M | -3.1M | -575K |
Other Non-Cash Items | -273K | 2.97M | 2.38M | -4.09M | -5.95M | 7.14M | -19.4M | -7.31M | 26M | -58.89M | 9.71M | -2.12M | 25.52M | 4M | 4.47M | 1.11M | 5.19M | 1.9M | 10.48M | -43.4M | 232K | 9.44M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -756K | -97K | -769K | -125K | 74K | -74K | -15K | n/a | n/a | 15K |
Change in Working Capital | 1M | -728K | -1.38M | -1.17M | -8.33M | 1.75M | -4.51M | -7.26M | 14.1M | -16.31M | 10.27M | 4.78M | -5.16M | -4.02M | 3.98M | 9.63M | 2.99M | -3.27M | 2.37M | 12.61M | -1.32M | 2.9M |
Operating Cash Flow | -70.19M | -32.96M | -30.94M | -26.96M | -34.71M | -32.64M | -39.7M | -44.05M | -35.14M | -51.97M | -40.6M | -38.67M | -79.28M | -49.28M | -37.33M | -33.2M | -43.03M | -50.2M | -37.02M | -33.49M | -46.11M | -37.47M |
Capital Expenditures | -34K | -34K | n/a | n/a | n/a | n/a | n/a | n/a | -181K | -40K | -173K | -91K | -319K | n/a | -160K | -1.66M | -278K | -450K | -2.19M | -2.66M | -819K | -436K |
Cash Acquisitions | n/a | n/a | 569K | n/a | 564K | 5K | n/a | n/a | 65K | n/a | n/a | 117.36K | -73.25K | n/a | 11.73K | -21.68K | 141.82K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -59.93M | -29.95M | -30.24M | -49.53M | -40.19M | -19.53M | -39.22M | -59.24M | -19.39M | -10.12M | -95.99M | -264.11M | -125.21M | -63.88M | -125.98M | -129.6M | -198.32M | -79.25M | -83.22M | -202.47M | -23.38M | -54.43M |
Sales Maturities Of Investments | 120M | 60M | 62.56M | 77.86M | 70M | 60M | 71.5M | 107.48M | 54M | 71.7M | 54.1M | 146.75M | 198.46M | 106M | 114.25M | 151.28M | 56.5M | 99.5M | 128.68M | 78.01M | 90.8M | 68.33M |
Other Investing Acitivies | n/a | n/a | -440K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -117.36K | 73.25K | n/a | -11.73K | 21.68K | -141.82K | n/a | n/a | -14.32M | n/a | n/a |
Investing Cash Flow | 60.04M | 30.01M | 32.45M | 28.32M | 30.38M | 40.48M | 32.28M | 48.24M | 34.49M | 61.55M | -42.06M | -117.45M | 72.93M | 42.12M | -11.89M | 20.02M | -142.1M | 19.8M | 43.27M | -141.44M | 66.6M | 13.46M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.45M | -1.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -241K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.15M | 386K | -386K | n/a |
Financial Cash Flow | -1.06M | -1.12M | -4.59M | 115K | n/a | 189K | n/a | 92K | 9K | 7K | n/a | 309K | 236.62M | 373K | 49.74M | 589K | 209.46M | 1.26M | 12.27M | 166.57M | -316K | n/a |
Net Cash Flow | -11.21M | -4.07M | -3.08M | 1.47M | -4.33M | 8.03M | -7.42M | 4.34M | -640K | 9.58M | -82.71M | -155.81M | 230.28M | -6.79M | 518K | -12.59M | 24.33M | -29.14M | 18.91M | -8.36M | 20.17M | -25.96M |
Free Cash Flow | -70.23M | -32.99M | -30.94M | -26.96M | -34.71M | -32.64M | -39.7M | -44.05M | -35.32M | -52.01M | -40.77M | -38.76M | -79.59M | -49.28M | -37.49M | -34.86M | -43.31M | -50.65M | -39.21M | -36.15M | -46.93M | -37.91M |
Adj. Free Cash Flow | -76.64M | -32.99M | -34.06M | -31.79M | -40.99M | -39.12M | -71.07M | -54.41M | -48.03M | -64.85M | -40.77M | -52.62M | -92.94M | -63.02M | -47.1M | -45.18M | -60.07M | -60.79M | -39.21M | -43.81M | -56.85M | -37.91M |
Maintenance CapEx | -34K | -34K | n/a | n/a | n/a | n/a | n/a | n/a | -181K | n/a | -173K | -91K | -319K | n/a | -160K | -1.66M | -278K | -450K | -2.19M | -2.66M | -819K | -436K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -40K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -70.23M | -32.99M | -30.94M | -26.96M | -34.71M | -32.64M | -39.7M | -44.05M | -35.32M | -51.97M | -40.77M | -38.76M | -79.59M | -49.28M | -37.49M | -34.86M | -43.31M | -50.65M | -39.21M | -36.15M | -46.93M | -37.91M |
Add to Watchlist
Select watchlists to add or remove ZNTL